Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ: ZNTL · Real-Time Price · USD

5.20

-0.36 (-6.47%)

At close: Apr 14, 2026, 4:00 PM EDT

5.25

+0.05 (0.90%)

After-hours: Apr 14, 2026, 6:40 PM EDT

Zentalis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36	33.9	28.04	43.07	59.71
Short-Term Investments	209.9	337.18	454.88	394.3	280.17
Cash & Short-Term Investments	245.89	371.08	482.92	437.37	339.89
Cash Growth	-33.74%	-23.16%	10.41%	28.68%	0.41%
Accounts Receivable	-	5	-	-	-
Other Current Assets	7.3	9.98	13.8	14.56	10.88
Total Current Assets	253.19	386.07	496.72	451.93	350.77
Net Property, Plant & Equipment	29.04	37.23	41.74	50.08	52.84
Goodwill	-	-	3.74	3.74	3.74
Long-Term Investments	-	-	-	21.21	37.5
Other Long-Term Assets	6.74	7.04	9.5	12.35	9.67
Total Assets	288.97	430.34	551.69	539.31	454.51
Accounts Payable	7.21	7.44	14.93	11.25	11.59
Accrued Expenses	29.35	45.29	54.44	45.4	32.35
Total Current Liabilities	36.56	52.73	69.37	56.65	43.94
Long-Term Leases	35.7	39.58	43.15	45.17	44.46
Other Long-Term Liabilities	0.5	0.85	1.78	3.47	1.62
Total Long-Term Liabilities	36.2	40.43	44.93	48.64	46.08
Total Liabilities	72.76	93.15	114.3	105.29	90.03
Common Stock	0.07	0.07	0.07	0.06	0.05
Additional Paid-in Capital	1,407	1,391	1,324	1,031	723.59
Accumulated Other Comprehensive Income	0.2	0.56	2.19	-1.35	-0.13
Retained Earnings	-1,191	-1,054	-888.56	-596.37	-359.56
Total Common Shareholders' Equity	216.2	337.19	437.28	433.8	363.95
Minority Interest	-	-	0.11	0.22	0.53
Shareholders' Equity	216.2	337.19	437.39	434.02	364.48
Total Liabilities & Equity	288.97	430.34	551.69	539.31	454.51
Total Debt	35.7	39.58	43.15	45.17	44.46
Net Cash (Debt)	210.19	331.51	439.77	392.21	295.43
Net Cash Growth	-36.60%	-24.62%	12.13%	32.76%	-12.44%
Net Cash Per Share	2.92	4.66	6.72	7.42	6.92
Book Value	216.2	337.19	437.28	433.8	363.95
Book Value Per Share	3.01	4.74	6.69	8.21	8.53
Tangible Book Value	216.2	337.19	433.55	430.07	360.22
Tangible Book Value Per Share	3.01	4.74	6.63	8.14	8.44

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q